Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome

• मुख्य लेखकों: Clément François (लेखक), John M. Stern (लेखक), Augustina Ogbonnaya (लेखक), Tasneem Lokhandwala (लेखक), Pamela Landsman-Blumberg (लेखक), Amy Duhig (लेखक), Vivienne Shen (लेखक), Robin Tan (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Taylor & Francis Group, 2017-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background: Lennox-Gastaut syndrome (LGS) is a severe form of childhood-onset epilepsy associated with serious injuries due to frequent and severe seizures. Of the antiepileptic drugs (AEDs) approved for LGS, clobazam is a more recent market entrant, having been approved in October 2011. Recent AED...